Title : Effect of calcifediol treatment on cardiovascular outcomes in patients with acute coronary syndrome and percutaneous revascularization.

Pub. Date : 2018 Nov 9

PMID : 29306481






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Basal levels of 25(OH)D<=50nmol/L were associated with multivessel coronary artery disease (RR: 2.6 [CI 95%:1.1-7.1], P=.027) and 25(OH)D<=50nmol/L+parathormone >=65pg/mL levels correlated with increased risk for MACE (RR: 4 [CI 95%: 1.1-21.8], P=.04]. 25(oh)d thrombopoietin Mus musculus
2 RESULTS: Basal levels of 25(OH)D<=50nmol/L were associated with multivessel coronary artery disease (RR: 2.6 [CI 95%:1.1-7.1], P=.027) and 25(OH)D<=50nmol/L+parathormone >=65pg/mL levels correlated with increased risk for MACE (RR: 4 [CI 95%: 1.1-21.8], P=.04]. 25(oh)d thrombopoietin Mus musculus
3 RESULTS: Basal levels of 25(OH)D<=50nmol/L were associated with multivessel coronary artery disease (RR: 2.6 [CI 95%:1.1-7.1], P=.027) and 25(OH)D<=50nmol/L+parathormone >=65pg/mL levels correlated with increased risk for MACE (RR: 4 [CI 95%: 1.1-21.8], P=.04]. 25(oh)d thrombopoietin Mus musculus
4 Among patients with 25(OH)D levels<=50nmol/L at the end of the study, 28.6% had MACE versus 0% among patients with 25(OH)D>50nmol/L (RR: 1,4; P=.037). 25(oh)d thrombopoietin Mus musculus
5 25(OH)D levels<=50nmol/L at the end of the intervention period were significantly associated with an increased number of MACE, hence, 25(OH)D level normalisation could improve cardiovascular health in addition to bone health. 25(oh)d thrombopoietin Mus musculus